0.169
1.20%
0.002
アフターアワーズ:
.17
0.001
+0.59%
前日終値:
$0.167
開ける:
$0.165
24時間の取引高:
454.21K
Relative Volume:
0.38
時価総額:
$10.62M
収益:
$1.16M
当期純損益:
$-37.28M
株価収益率:
-0.26
EPS:
-0.65
ネットキャッシュフロー:
$-33.81M
1週間 パフォーマンス:
+2.74%
1か月 パフォーマンス:
-4.14%
6か月 パフォーマンス:
-94.37%
1年 パフォーマンス:
-88.73%
Glycomimetics Inc Stock (GLYC) Company Profile
名前
Glycomimetics Inc
セクター
電話
240-243-1201
住所
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-11-12 | アップグレード | Jefferies | Hold → Buy |
2019-11-14 | 開始されました | ROTH Capital | Buy |
2019-08-05 | ダウングレード | Jefferies | Buy → Hold |
2019-08-05 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2019-08-05 | ダウングレード | SunTrust | Buy → Hold |
2019-04-12 | 開始されました | Piper Jaffray | Overweight |
2018-12-18 | 開始されました | H.C. Wainwright | Buy |
2016-07-26 | 開始されました | SunTrust | Buy |
2015-03-17 | 繰り返されました | Stifel | Buy |
すべてを表示
Glycomimetics Inc (GLYC) 最新ニュース
GlycoMimetics Inc [GLYC] Records 50-Day SMA of $0.1928 - Knox Daily
GLYC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
GlycoMimetics Inc [GLYC] Stock sold by Insider Invus Public Equities, L.P. for $50009.0 - Knox Daily
Capital One Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN
Market Insights: GlycoMimetics Inc (GLYC)’s Notable Drop of -0.18, Closing at 0.16 - The Dwinnex
Is GlycoMimetics Inc (GLYC) a threat to investors? - US Post News
GlycoMimetics Inc [NASDAQ: GLYC] Sees Decrease in Stock Value - Knox Daily
Analytical Lens: Exploring GlycoMimetics Inc (GLYC)’s Financial Story Through Ratios - The Dwinnex
India Glycols receives revision in credit rating from CARE - Business Standard
CARE Ratings affirms 'A-' rating of India Glycols with 'stable' outlook - Business Standard
StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDG - BioSpace
Galmed Pharmaceuticals Soars Nearly 500% Amid Nasdaq Compliance and Short Squeeze - TipRanks
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat
GlycoMimetics Inc [GLYC] Investment Appeal on the Rise - Knox Daily
Short Interest in GlycoMimetics, Inc. (NASDAQ:GLYC) Decreases By 16.5% - Defense World
TD Cowen’s latest rating for GLYC stock - Knox Daily
Closing Figures: GlycoMimetics Inc (GLYC)’s Negative Finish at 0.16, Down -2.82 - The Dwinnex
GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World
Wall Street analysts’ outlook for GlycoMimetics Inc (GLYC) - SETE News
GLYC’s Debt-to-Equity Ratio at 0.02: What It Means for GlycoMimetics Inc’s Future - The InvestChronicle
GlycoMimetics stock plunges to 52-week low of $0.16 - Investing.com
GlycoMimetics stock plunges to 52-week low of $0.16 By Investing.com - Investing.com UK
Trading Day Review: GlycoMimetics Inc (GLYC) Gains Momentum, Closing at 0.18 - The Dwinnex
GlycoMimetics Inc (GLYC) did well last session? - US Post News
GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews.com - Defense World
GLYC Shares Experience Decline in Value - Knox Daily
GLYC’s Stock Dilemma: GlycoMimetics Inc’s Market Performance and Outlook - The InvestChronicle
Stocks of GlycoMimetics Inc (GLYC) are poised to climb above their peers - SETE News
GlycoMimetics Inc [GLYC] stock was sold by Invus Public Equities, L.P. at the price of US$50009.0 - Knox Daily
Balance Sheet Insights: GlycoMimetics Inc (GLYC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World
GlycoMimetics Inc [GLYC] 10% Owner makes an insider purchase of 260,873 shares worth 50009.0. - Knox Daily
GlycoMimetics Inc [GLYC] Is Currently 8.70 above its 200 Period Moving Avg: What Does This Mean? - The DBT News
Nothing is Better Than GlycoMimetics Inc (GLYC) stock at the moment - SETE News
GlycoMimetics Inc [GLYC] Investment Appeal on the Rise - Knoxdaily.com
GlycoMimetics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
GlycoMimetics Inc (GLYC)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
A stock that deserves closer examination: GlycoMimetics Inc (GLYC) - US Post News
StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World
Analyzing GlycoMimetics (NASDAQ:GLYC) and Fulcrum Therapeutics (NASDAQ:FULC) - Defense World
Taking a look at what insiders are doing to gauge the GlycoMimetics Inc (GLYC)’s direction - Knox Daily
Vanguard Group Inc. Raises Stake in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World
GlycoMimetics Inc (GLYC) Stock: A Year of Stock Market Dynamics - The InvestChronicle
GlycoMimetics Inc (GLYC) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress - GlobeNewswire Inc.
Potential Price Increase for GlycoMimetics Inc (GLYC) After Recent Insider Activity - Knoxdaily.com
GlycoMimetics stock plunges to 52-week low of $0.17 By Investing.com - Investing.com Australia
It would be worthwhile to take a closer look at GlycoMimetics Inc (GLYC) - US Post News
GlycoMimetics stock plunges to 52-week low of $0.17 - Investing.com
GlycoMimetics stock plunges to 52-week low of $0.17 By Investing.com - Investing.com UK
Glycomimetics Inc (GLYC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):